Business

Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results

Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results Canada...

articleCannara Biotech, Inc.January 20, 20225/company/cannara-biotech-inc-1/news/cannara-biotech-inc-reports-fiscal-first-quarter-2022-financial-results
Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results

About this update from Cannara Biotech, Inc.

[{"type":"text","content":"\n \n \n \n Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prngen3{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: BOTTOM; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prngen4{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: BOTTOM; TEXT-ALIGN: RIGHT; BORDER-BOTTOM:black 1pt solid\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE; BORDER-TOP:1pt black; BORDER-RIGHT:1pt black; BORDER-BOTTOM:1pt black; BORDER-LEFT:1pt black\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n Strong execution leads to third consecutive quarter of positive Adjusted EBITDA\n \n \n \n \n \n \n Company recorded quarterly revenues of\n \n $6.6 million\n \n \n \n \n \n \n \n Growing operations initiated at new Valleyfield Facility\n \n \n \n \n All financial results are reported in Canadian dollars, unless otherwise stated.\n \n \n \n MONTREAL\n \n ,\n \n January 20, 2022\n \n /CNW Telbec/ -\n \n Cannara Biotech Inc.\n \n (\"\n \n Cannara\n \n \" or the \"\n \n Company\n \n \") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced its fiscal first quarter of 2022 financial and operating results for the three-month period ended\n \n November 30, 2021\n \n .\n \n \n \n \n First fiscal Quarter of 2022 Financial and Operational Highlights\n \n \n \n \n \n \n Financial\n \n \n \n \n \n Posted quarterly revenues of\n \n $6.6 million\n \n ;\n \n \n Recorded a gross profit before fair value adjustments of\n \n $3.0 million\n \n or 46%;\n \n \n Achieved third consecutive quarter of posi...

More updates from Cannara Biotech, Inc.